Agree the possibility that the % balance is tipping the scales more than we understand; agree also the “presto” for a party siezing control is not far fetched. It’s almost a no brainer when reading between the lines of the market, the canniness of the manipulators, the silence of the Board and inaction by the regulators.
There are many possible scenarios, however, consider a part bid at $0.40 per share for 51% of all issued shares whilst the sp is around $0.25. That would of course be a manipulated, criminal steal well below current intrinsic value of $1.30 to $1.68 , according to analysts, and potentially >$6.00 long term (my guess).
However, in the current uncertain climate, both of sharemarkets and the company at crossroads (and not the least the sp collapse and the orchestrated shareholder disillusionment) coupled with a silent incumbent Board (until a bid hits the table) the $0.15 per share (+60%) premium would be an enticing ruse to weed out enough acceptances from retail holders (unsuspecting or not), when added to any silent supportive cohort already on the register, to deliver swift and effective control to the low ball bidder.
From day of control achieved by a change in directors voted by the 51% holder anything is possible. This may include prematurely selling off the two subsidiaries prior to further advancements of their medical breakthroughs.
Subsequently, the remaining retail holder lambs would be made a series of special offers over time to court them out and once 90% was reached by the bidder the remaining stock would be compulsory acquired. Finis!
Apart from our complaints to ASIC and ASX (please do so ASAP) we need the Board to take action to call on the CEO to immediately request an investigation of trading in CDY stock and associated happenings to expose the sp manipulation that is the only rational explanation for the shocking 69% collapse from 0.04c pre June 2017 (pre consolidation).
A decision to do nothing about this farce while we shareholders bleed should not be left to the CEO.
CDY Price at posting:
25.0¢ Sentiment: Buy Disclosure: Held
